Prostate Cancer, PSMA PET and Functional Imaging

PSMA-Targeted PET Imaging & Radioligand Therapy in the Management of Prostate CancerПодробнее

Advanced Imaging & Prostate Cancer: The Who, What, When, Where, and Why | ZERO Prostate CancerПодробнее

Functional Imaging and Recurring Prostate CancerПодробнее

PSMA-Targeted PET Imaging for Prostate CancerПодробнее

The Role of PSMA in Detection of Prostate Cancer Biochemical Recurrence After TreatmentПодробнее

MERIT Webinar: PCWG3 and Oncology Imaging EndpointsПодробнее

Optimizing Management of High-risk Prostate Cancer PatientsПодробнее

Thyroid Cancer Imaging Update with Dr. FlavellПодробнее

Benefits of PSMA-PET for High-risk/Advanced Prostate Cancer: Part 2Подробнее

Monitoring Response of metastatic castration resistance prostate cancer (mCRPC)Подробнее

Prof John Buscombe - Prostate PETПодробнее

Prostate Cancer Survivorship Series: Advances in Imaging TechnologyПодробнее

Advances in Imaging Technology: PET ScansПодробнее

PSMA PET and Functional Imaging - 2021 Prostate Cancer Patient ConferenceПодробнее

18F-fluciclovine PET in mCRPC treated with abiraterone acetateПодробнее

Next Gen Imaging for Adv Prostate Cancer - 2021 IssueПодробнее

Prostste Cancer imagingПодробнее

WARMTH ICRT 2020 - Oral AbstractsПодробнее

How and when should PET scans be used? What do they show? #myelomaПодробнее